Kuznetsov Sergey
Senior Scientist
Description
Keywords
breast cancer, Rad51c, BRCA1, GPRC5A, HTS
Affiliations
Institute for Molecular Medicine Finland
Senior Scientist
Primary
High Throughput Biomedicine Unit
2018 - present
Primary
Source: ORCID
University of Helsinki
FIMM-EMBL Group Leader
Institute for Molecular Medicine Finland (FIMM)
2008 - 2016
Source: ORCID
National Cancer Institute, NIH
post-doc
Mouse Cancer Genetics Program
2002 - 2008
Source: ORCID
Education (3)
PhD
1998 - 2002
University of Kiel
MSc
1995 - 1997
St. Petersburg State University
BSc
1990 - 1995
St. Petersburg State University
Publications (29)
2023
Nucleic Acids Research
Open access
Peer-reviewed
2021
2019
The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.
Granted funding (4)
Developing personalized therapeutic approaches for BRCA1-mutated breast cancers
Cancer Society of Finland
2011 - 2012
2011 - 2016
Identifying New Therapeutic Targets for Hereditary Breast Cancers
Research Council of Finland
2011 - 2016
IDENTIFYING NEW THERAPEUTIC TARGETS FOR HEREDITARY BREAST CANCERS
Research Council of Finland
2011 - 2016
Activities and awards (1)
Other activity
Functional Analysis of Human BRCA2 Variants Using a Mouse Embryonic Stem Cell-Based Assay
2010
International collaboration: No